Lawrence H. Lazarus

3.5k total citations
102 papers, 2.9k citations indexed

About

Lawrence H. Lazarus is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Lawrence H. Lazarus has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 88 papers in Cellular and Molecular Neuroscience and 12 papers in Physiology. Recurrent topics in Lawrence H. Lazarus's work include Neuropeptides and Animal Physiology (84 papers), Receptor Mechanisms and Signaling (64 papers) and Pharmacological Receptor Mechanisms and Effects (39 papers). Lawrence H. Lazarus is often cited by papers focused on Neuropeptides and Animal Physiology (84 papers), Receptor Mechanisms and Signaling (64 papers) and Pharmacological Receptor Mechanisms and Effects (39 papers). Lawrence H. Lazarus collaborates with scholars based in United States, Italy and Japan. Lawrence H. Lazarus's co-authors include Severo Salvadori, Sharon D. Bryant, Martti Attila, Remo Guerrini, Gianfranco Balboni, Yunden Jinsmaa, Clementina Bianchi, Yoshio Okada, Dongman Chao and Ying Xia and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Trends in Neurosciences.

In The Last Decade

Lawrence H. Lazarus

101 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence H. Lazarus United States 31 2.2k 2.1k 414 239 166 102 2.9k
Anna Borsodi Hungary 27 1.5k 0.7× 1.7k 0.8× 476 1.1× 92 0.4× 33 0.2× 158 2.4k
Gianfranco Balboni Italy 35 2.2k 1.0× 1.6k 0.8× 565 1.4× 781 3.3× 36 0.2× 163 3.6k
Bernadette Cusack United States 26 1.1k 0.5× 1.0k 0.5× 211 0.5× 148 0.6× 27 0.2× 47 2.0k
Cyril Goudet France 34 2.3k 1.1× 2.1k 1.0× 376 0.9× 161 0.7× 60 0.4× 68 3.3k
Peg Davis United States 34 2.7k 1.2× 2.2k 1.0× 631 1.5× 587 2.5× 68 0.4× 121 3.4k
Robert Galyean United States 18 900 0.4× 400 0.2× 152 0.4× 126 0.5× 49 0.3× 22 1.4k
John W. Ferkany United States 28 1.3k 0.6× 1.8k 0.8× 351 0.8× 118 0.5× 36 0.2× 59 2.5k
Mathias Hallberg Sweden 27 1.0k 0.5× 876 0.4× 396 1.0× 104 0.4× 25 0.2× 116 2.1k
George Liapakis Greece 25 2.1k 1.0× 1.3k 0.6× 110 0.3× 139 0.6× 19 0.1× 71 2.8k
Grazia Lombardi Italy 29 1.1k 0.5× 792 0.4× 216 0.5× 212 0.9× 36 0.2× 66 2.3k

Countries citing papers authored by Lawrence H. Lazarus

Since Specialization
Citations

This map shows the geographic impact of Lawrence H. Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence H. Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence H. Lazarus more than expected).

Fields of papers citing papers by Lawrence H. Lazarus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence H. Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence H. Lazarus. The network helps show where Lawrence H. Lazarus may publish in the future.

Co-authorship network of co-authors of Lawrence H. Lazarus

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence H. Lazarus. A scholar is included among the top collaborators of Lawrence H. Lazarus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence H. Lazarus. Lawrence H. Lazarus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Jun, Yu Ma, Bruce Wyse, et al.. (2014). Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity. Bioorganic & Medicinal Chemistry. 22(7). 2208–2219. 12 indexed citations
2.
Lazarus, Lawrence H. & Yoshio Okada. (2012). Engineering endomorphin drugs: state of the art. Expert Opinion on Therapeutic Patents. 22(1). 1–14. 9 indexed citations
3.
Koda, Yasuko, et al.. (2008). Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorganic & Medicinal Chemistry. 16(11). 6286–6296. 47 indexed citations
4.
Ballet, Steven, Ewa D. Marczak, Severo Salvadori, et al.. (2008). Conformationally constrained opioid ligands: The Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold. Bioorganic & Medicinal Chemistry Letters. 19(2). 433–437. 17 indexed citations
5.
Marczak, Ewa D., Yunden Jinsmaa, Tingyou Li, et al.. (2007). [N-Allyl-Dmt1]-Endomorphins Are μ-Opioid Receptor Antagonists Lacking Inverse Agonist Properties. Journal of Pharmacology and Experimental Therapeutics. 323(1). 374–380. 11 indexed citations
6.
7.
Salvadori, Severo, Claudio Trapella, Lucia Negri, et al.. (2007). A new opioid designed multiple ligand derived from the μ opioid agonist endomorphin-2 and the δ opioid antagonist pharmacophore Dmt-Tic. Bioorganic & Medicinal Chemistry. 15(22). 6876–6881. 22 indexed citations
8.
Li, Tingyou, Yuko Tsuda, Toshio Yokoi, et al.. (2007). Design and synthesis of opioidmimetics containing 2′,6′-dimethyl-l-tyrosine and a pyrazinone-ring platform. Bioorganic & Medicinal Chemistry Letters. 17(21). 5768–5771. 6 indexed citations
9.
Balboni, Gianfranco, Valentina Onnis, Cenzo Congiu, et al.. (2006). Effect of Lysine at C-Terminus of the Dmt-Tic Opioid Pharmacophore. Journal of Medicinal Chemistry. 49(18). 5610–5617. 21 indexed citations
10.
Jinsmaa, Yunden, Ewa D. Marczak, Yoshio Fujita, et al.. (2006). Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1. Pharmacology Biochemistry and Behavior. 84(2). 252–258. 17 indexed citations
11.
Balboni, Gianfranco, Maria Teresa Cocco, Severo Salvadori, et al.. (2005). From the Potent and Selective μ Opioid Receptor Agonist H-Dmt-d-Arg-Phe-Lys-NH2 to the Potent δ Antagonist H-Dmt-Tic-Phe-Lys(Z)-OH. Journal of Medicinal Chemistry. 48(17). 5608–5611. 5 indexed citations
12.
Jinsmaa, Yunden, Yoshio Okada, Yuko Tsuda, et al.. (2004). Novel 2′,6′-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic μ-Agonists with Potent Antinociceptive Activity in Mice. Journal of Pharmacology and Experimental Therapeutics. 309(1). 432–438. 40 indexed citations
13.
Fujita, Yoshio, Yuko Tsuda, Tingyou Li, et al.. (2004). Studies on the structure–activity relationship of 2′,6′-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H–Dmt–NH–CH3. Bioorganic & Medicinal Chemistry Letters. 15(3). 599–602. 8 indexed citations
14.
Okada, Yoshio, Yoshio Fujita, Yuko Tsuda, et al.. (2003). Structural studies of [2′,6′-dimethyl-l-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond. Bioorganic & Medicinal Chemistry. 11(9). 1983–1994. 45 indexed citations
15.
Balboni, Gianfranco, Remo Guerrini, Severo Salvadori, et al.. (2002). Evaluation of the Dmt−Tic Pharmacophore:  Conversion of a Potent δ-Opioid Receptor Antagonist into a Potent δ Agonist and Ligands with Mixed Properties. Journal of Medicinal Chemistry. 45(3). 713–720. 77 indexed citations
16.
Labarre, Maryse, Joanne Butterworth, Stéphane St-Onge, et al.. (2000). Inverse agonism by Dmt–Tic analogues and HS 378, a naltrindole analogue. European Journal of Pharmacology. 406(1). R1–R3. 24 indexed citations
17.
Crescenzi, Orlando, Franca Fraternali, Delia Picone, et al.. (1997). Design and Solution Structure of a Partially Rigid Opioid Antagonist Lacking the Basic Center — Models of Antagonism. European Journal of Biochemistry. 247(1). 66–73. 18 indexed citations
18.
Guerrini, Remo, Girolamo Calò, Anna Rizzi, et al.. (1997). Address and Message Sequences for the Nociceptin Receptor:  A Structure−Activity Study of Nociceptin-(1−13)-peptide amide. Journal of Medicinal Chemistry. 40(12). 1789–1793. 192 indexed citations
19.
Guerrini, Remo, Anna Capasso, L. Sorrentino, et al.. (1996). Opioid receptor selectivity alteration by single residue replacement: synthesis and activity profile of [Dmt1]deltorphin B. European Journal of Pharmacology. 302(1-3). 37–42. 34 indexed citations
20.
Salvadori, Severo, et al.. (1992). Para-substituted Phe3 deltorphin analogs: enhanced selectivity of halogenated derivatives for .sigma. opioid receptor sites. Journal of Medicinal Chemistry. 35(25). 4651–4657. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Borsodi Breakdown of academic impact, for papers by Gianfranco Balboni Breakdown of academic impact, for papers by Bernadette Cusack Breakdown of academic impact, for papers by Cyril Goudet Breakdown of academic impact, for papers by Peg Davis Breakdown of academic impact, for papers by Robert Galyean Breakdown of academic impact, for papers by John W. Ferkany Breakdown of academic impact, for papers by Mathias Hallberg Breakdown of academic impact, for papers by George Liapakis Breakdown of academic impact, for papers by Grazia Lombardi
Rankless by CCL
2026